Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 72 recruiting studies, sorted by proximity — each links to its official registry page
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 490 participants sought
Cancer Care Centers of Brevard- Rockledge /ID# 277853 — Rockledge, Florida (27.1 mi)
· Sponsor: AbbVie
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: Akero Therapeutics, Inc
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Cancer Care Centers of Brevard Palm Bay — Palm Bay, Florida (6.5 mi)
· Sponsor: BeOne Medicines
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
Phase 3
Interventional 350 participants sought
Ep0162 50703 — Rockledge, Florida (27.1 mi)
· Sponsor: UCB Biopharma SRL
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Cancer Care Centers of Breevard — Rockledge, Florida (27.1 mi)
· Sponsor: Revolution Medicines, Inc.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Melbourne, Florida (8.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Relay Therapeutics, Inc.
The Preeclampsia Registry
Preeclampsia, Eclampsia
N/A
Observational 20,000 participants sought
Preeclampsia Foundation — Melbourne, Florida (8.9 mi)
· Sponsor: Preeclampsia Foundation
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Neurocrine Biosciences
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Phase 3
Interventional 400 participants sought
Vero Beach Neurology — Vero Beach, Florida (27.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Clincloud, LLC - Viera Office — Melbourne, Florida (8.9 mi)
· Sponsor: Alpha Cognition, Inc
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Breast Cancer
Phase 3
Interventional 420 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: Hoffmann-La Roche
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Breast Cancer
Phase 3
Interventional 625 participants sought
Research Site — Palm Bay, Florida (6.5 mi)
· Sponsor: AstraZeneca
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular & Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Versono Medical Ltd
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,560 participants sought
AURORA-2 Clinical Site — Melbourne, Florida (8.9 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 550 participants sought
Neurocrine Clinical Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Neurocrine Biosciences
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Panoramic Health - Florida Kidney Physicians, LLC (Melbourne) — Melbourne, Florida (8.9 mi)
· Sponsor: Takeda
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Florida Pain Institute — Merritt Island, Florida (27.4 mi)
· Sponsor: Boston Scientific Corporation
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Neovascular Age-Related Macular Degeneration
Phase 3
Interventional 1,000 participants sought
Florida Eye Associates — Melbourne, Florida (8.9 mi)
· Sponsor: Hoffmann-La Roche
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Gilead Sciences
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Seaport Therapeutics
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Osteoarthritis, Knee, Chronic Pain
Phase 2
Interventional 150 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company